The rising prevalence of cancer population, low risk of treatment induced disorders, potential for retreatment owing to low radiation dose, and rising number of particle therapy centers across the world are expected to drive the growth of the market. Moreover, rising R&D spending and aggressive strategies adopted by the top players such as new product launches are contributing to the growth of the market. For instance, in December 2017, Advanced Oncotherapy plc announced that it secures ... Read more
Particle therapy is one of the world's most advanced areas of external beam radiation therapy applied to oncology. This technique saves healthier radiation tissue better than conventional photon therapy. These particles have more favorable physical intrinsic properties that reduce the intake dose to approximately 50% of the dose in a clinically relevant target.
The Global Particle Therapy Market is accounted for USD 790.45 million in 2017 and ... Read more
It is predicted that the global teleradiology market will have a good run in the future because of the development of sundry wireless technologies that can transfer images continuously and quickly. All the institutions in the world that deal with afterhours imaging services across the globe that have varying time zones yet offer day time reporting are predicted to boost the global ... Read more
Global Particle Therapy Market was valued US$ 860 Mn in 2017 and is expected to reach US$ 1842 Mn by 2026, at a CAGR of 9.99% during a forecast period.
The particle therapy market is majorly segmented into type, product & service, system, cancer type, application, and region.
Further, particle therapy market based on type includes proton therapy, ... Read more
Particle therapy is one of the world's most advanced areas of external beam radiation therapy applied to oncology. This technique saves healthier radiation tissue better than conventional photon therapy. These particles have more favorable physical intrinsic properties that reduce the intake dose to approximately 50% of the dose in a clinically relevant target.
The Global Particle Therapy Market is accounted for USD 790.45 million in 2017 and ... Read more
Particle therapy is one of the world's most advanced areas of external beam radiation therapy applied to oncology. This technique saves healthier radiation tissue better than conventional photon therapy. These particles have more favorable physical intrinsic properties that reduce the intake dose to approximately 50% of the dose in a clinically relevant target.
The Global Particle Therapy Market is accounted for USD 790.45 million in 2017 and expected to register 9.1% CAGR during the ... Read more
Transparency Market Research (TMR) anticipates that the particle therapy market features fragmented vendor landscape owing to a large number of key players operating in the market. Varian Medical Systems, Inc., IBA Worldwide, Hitachi, Ltd., and Sumitomo Heavy Industries, Ltd are some of the key players in the global particle therapy market.
According to TMR, the market stood at a value of US$ 364.8 ... Read more
Global Particle Therapy Market: Information by Type (Proton Therapy & Heavy Ion Therapy), Product & Service (Products & Others), Cancer Type (Prostate, Lung), System (Multi-Room & Single Room), Application (Treatment & Research) — Forecast till 2023
Market Scenario:
Particle therapy is one of the world's most advanced areas of external beam radiation therapy applied to oncology. This technique saves healthier radiation ... Read more
Growth in the particle therapy market is primarily driven by factors such as the various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide.
According to the new market research report “Particle Therapy Market ... Read more
Particle therapy is one of the world's most advanced areas of external beam radiation therapy applied to oncology. This technique saves healthier radiation tissue better than conventional photon therapy. These particles have more favorable physical intrinsic properties that reduce the intake dose to approximately 50% of the dose in a clinically relevant target.
The Global Particle Therapy Market is accounted for USD 790.45 million in 2017 and ... Read more
Transparency Market Research (TMR) anticipates that the particle therapy market features fragmented vendor landscape owing to a large number of key players operating in the market. Varian Medical Systems, Inc., IBA Worldwide, Hitachi, Ltd., and Sumitomo Heavy Industries, Ltd are some of the key players in the global particle therapy market.
According to TMR, the market stood at a value of US$ 364.8 ... Read more